GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » Short-Term Debt

Euroapi (LTS:0EAP) Short-Term Debt : €50.7 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Short-Term Debt?

Euroapi's Short-Term Debt for the quarter that ended in Dec. 2024 was €50.7 Mil.

Euroapi's quarterly Short-Term Debt increased from Dec. 2023 (€205.4 Mil) to Jun. 2024 (€452.8 Mil) but then declined from Jun. 2024 (€452.8 Mil) to Dec. 2024 (€50.7 Mil).

Euroapi's annual Short-Term Debt increased from Dec. 2022 (€100.1 Mil) to Dec. 2023 (€205.4 Mil) but then declined from Dec. 2023 (€205.4 Mil) to Dec. 2024 (€50.7 Mil).

Euroapi Short-Term Debt Historical Data

The historical data trend for Euroapi's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Short-Term Debt Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial 55.80 1.40 100.10 205.40 50.70

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.10 200.30 205.40 452.80 50.70

Euroapi Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Euroapi Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Euroapi's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroapi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » Short-Term Debt
Comparable Companies
XPAR:AB XPAR:BOI XPAR:ALRPD XPAR:MLCOT XPAR:VETO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR
Traded in Other Exchanges
EAPIF:USA EAPI:France 940:Germany
Address
15 rue Traversiere, Paris, FRA, 75012
Website
https://www.euroapi.com
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines